MORGAN STANLEY - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 2 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2022$125,000
-60.1%
542,527
-38.2%
0.00%
Q4 2021$313,000
+99.4%
877,361
+234.3%
0.00%
Q3 2021$157,000
-50.0%
262,449
-7.3%
0.00%
Q2 2021$314,000
-13.0%
282,987
+0.2%
0.00%
Q1 2021$361,000282,342
+46800.7%
0.00%
Q4 2020$0
-100.0%
602
+0.3%
0.00%
Q3 2020$1,000600
+29900.0%
0.00%
Q2 2020$02
+100.0%
0.00%
Q1 2020$01
-50.0%
0.00%
Q4 2019$020.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 432,503$554,0000.09%
MONECO Advisors, LLC 35,000$45,0000.02%
Purus Wealth Management, LLC 15,000$19,0000.02%
Renaissance Technologies 8,454,364$10,822,0000.01%
LMR Partners LLP 390,864$500,0000.01%
ExodusPoint Capital Management, LP 595,459$762,0000.01%
LINCOLN CAPITAL CORP 12,000$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 264,500$339,0000.01%
HRT FINANCIAL LP 347,816$445,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 25,000$32,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders